Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05457491 · ClinicalTrials.gov registry record · Phase 1
Novel Antiaging Regenerative Skin Care Regimen Containing Human Platelet Extract (HPE)
A Phase 1 study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- Phase 1
- Development phase
- 56
- Enrollment target
NCT05457491: Clinical Trial Phase 1 study, sponsored by Mayo Clinic.
NCT05457491 is a Phase 1 study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 56 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05457491, a Phase 1 study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 56 participants
- Enrollment target
Study Summary
The Researchers are trying to study a cosmetic skin care product called human platelet extract (HPE) to see if it can be used as a possible treatment for skin anti-aging and skin rejuvenation. They are trying find out the safety and tolerability of topical HPE after multiple doses of topical administration
Interventions
- BIOLOGICAL Human platelet extract (cosmetic product)
- OTHER Vanicream Gentle Facial Cleanser
- OTHER EltaMD UV Daily Broad-Spectrum SPF 40
- OTHER EltaMD PM Therapy Facial Moisturizer
- OTHER Vanicream Lite Lotion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2021-10-01 |
| Est. Completion | 2022-07-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05457491
The ClinicalTrials.gov registry entry for NCT05457491 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Human platelet extract (cosmetic product) is the first listed.
NCT05457491 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05457491 about?
NCT05457491 is a clinical study titled "Novel Antiaging Regenerative Skin Care Regimen Containing Human Platelet Extract (HPE)". The Researchers are trying to study a cosmetic skin care product called human platelet extract (HPE) to see if it can be used as a possible treatment for skin anti-aging and skin rejuvenation. They are trying find out the safety and tolerability of topical HPE after multiple doses of topical adminis...
What is the current status of trial NCT05457491?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2021-10-01. Estimated completion is 2022-07-07.
What interventions are being tested in trial NCT05457491?
The interventions under investigation include: Human platelet extract (cosmetic product) (BIOLOGICAL), Vanicream Gentle Facial Cleanser (OTHER), EltaMD UV Daily Broad-Spectrum SPF 40 (OTHER), EltaMD PM Therapy Facial Moisturizer (OTHER), Vanicream Lite Lotion (OTHER).
Who is sponsoring clinical trial NCT05457491?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.